Evaluation of corticosteroids intended for use as topical anti-inflammatory drugs.
D000080:Acetals / Q000627:therapeutic use; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001623:Betamethasone / Q000627:therapeutic use; D002057:Burns, Chemical / Q000139:chemically induced / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D006914:Hydroxysteroids / Q000627:therapeutic use; D007664:Ketosteroids / Q000627:therapeutic use; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011246:Pregnadienetriols / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use; D011409:Propylene Glycols / Q000009:adverse effects; D012995:Solubility; D013258:Steroids, Chlorinated / Q000627:therapeutic use; D013259:Steroids, Fluorinated / Q000627:therapeutic use; D013997:Time Factors; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014631:Valerates / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014867:Water / Q000627:therapeutic use
D000080:Acetals; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006914:Hydroxysteroids; D007664:Ketosteroids; D011246:Pregnadienetriols; D011282:Pregnenediones; D011409:Propylene Glycols; D013258:Steroids, Chlorinated; D013259:Steroids, Fluorinated; D014631:Valerates; D014662:Vasoconstrictor Agents; D014867:Water; D001623:Betamethasone; D014222:Triamcinolone Acetonide